Choosing Wisely in educating future African oncologists

Navigating evidence-based care with limited resources in Africa

Choosing Wisely in surgical oncology

Choosing Wisely in pathology

Raising awareness of the burden of cervical cancer in the Eastern Mediterranean region

Cabozantinib after checkpoint inhibitors demonstrates preliminary efficacy in advanced RCC

Final OS results of IMvigor130: Atezolizumab plus platinum/gemcitabine for mUC

Gemcitabine, cisplatin plus nivolumab achieves clinical complete response in subset of muscle-invasive bladder cancer patients

Adjuvant nivolumab as standard of care for high-risk muscle-invasive urothelial carcinoma after radical resection

Hypofractionated high dose intensity modulated radiotherapy non-inferior for prostate cancer

Abiraterone acetate/prednisone + apalutimide and ADT with post-op SRT may improve PFS and MFS after prostatectomy

HER2DX: a new diagnostic tool for early-stage HER2 positive breast cancer